Deciphera

Why Shares of Deciphera Pharmaceuticals Rose This Week
Motley Fool
Sun, 08/13/23 - 02:34 pm
Deciphera
earnings
Qinlock
GIST
ESMO 2022 movers – KRAS backfires
EP Vantage
Thu, 09/15/22 - 10:12 am
ESMO
KRAS inhibitors
Relay Therapeutics
Regeneron
Amgen
Deciphera
Clovis Oncology
Ayala Pharmaceuticals
Springworks
Mirati Therapeutics
3 Biotech Stocks With Huge Catalysts Incoming
Motley Fool
Fri, 10/22/21 - 11:19 am
BeyondSpring
Allakos
Deciphera
plinabulin
lirentelimab
Qinlock
FDA approval tracker: several early decisions in May
EP Vantage
Wed, 06/3/20 - 10:24 am
FDA
Deciphera
Qinlock
Blueprint Medicines
Ayvakit
Eli Lilly
Retevmo
Bristol-Myers Squibb
Opdivo
Yervoy
Deciphera fills in where Blueprint falls short with early FDA nod in rare stomach cancer
Fierce Pharma
Mon, 05/18/20 - 10:59 pm
Blueprint Medicines
Deciphera
FDA
GIST
Ayvakit
Qinlock
Deciphera files for approval of cancer drug ahead of schedule
Fierce Biotech
Mon, 12/16/19 - 10:44 am
Deciphera
ripretinib
gastrointestinal stromal tumors
FDA
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Sun, 10/27/19 - 10:55 pm
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Deciphera soars as phase 3 cancer data tee up FDA filing
Fierce Biotech
Tue, 08/13/19 - 10:19 am
Deciphera
clinical trials
ripretinib
gastrointestinal stromal tumors
Deciphera expands cancer trial after seeing early data
Fierce Biotech
Wed, 01/2/19 - 11:13 am
Deciphera
DCC-3014
TGCTs
cancer
clinical trials
ASCO spotlight presaged two more biotech IPOs angling for $215M
Endpoints
Tue, 09/5/17 - 09:35 am
ASCO
IPOs
biotech
Deciphera
DCC-2618
Nucana
Acelarin